Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
STOK | Stoke Therapeutics, Inc. | CEO, Director | $2.09M | -$722K | -25.7% | May 20, 2024 |
CYTK | CYTOKINETICS INC | Director | $1.34M | Oct 1, 2024 | ||
RNA | Avidity Biosciences, Inc. | Director | Jun 13, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|